Breaking News, Promotions & Moves

AVI BioPharma

Peter S. Linsley, Ph.D., has been appointed chief scientific officer of AVI BioPharma, Inc., effective May 1, 2011.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Peter S. Linsley, Ph.D., has been appointed chief scientific officer of AVI BioPharma, Inc., effective May 1, 2011. Dr. Linsley is recognized industry-wide for his RNA- and microRNA-focused research as well as his work in advancing scientific discoveries into clinical development. He will be charged with continuing AVI’s strategy to create a world-class executive leadership team. Prior to joining the company, Dr. Linsley was chief scientific officer of Regulus Therapeutics, a joint venture of...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters